Anxiety F32
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Arabic speaking Access to iphone (min iOS8) while in treatment
Exclusion criteria
Exclusion criteria: extensive, current suicidality severe depressive symptoms (BDI > 28) other parallel psycho therapeutic treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of despressive symptoms: Becks – Depressionsinventar – II Measuring times: Baseline; Post-treatment; Follow-up Change of depressive symptoms: Patient Health Questionnaire – depression modul Measuring times: Baseline; before each new modul; Post-treatment; Follow-up at 6, 12 and 18 weeks post-treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measurements: Rumination: Perseverative Thinking Questionnaire Measuring times: Baseline; intermediate testing, Post-treatment; Follow-up Anxiety: Patient Health Questionnaire – Modul Generalized Anxiety Measuring times: Baseline; Post-treatment; Follow-up Wellbeing: Wellbeing Index – WHO-5 Emotionalal Self-efficacy: Emotional self-efficacy subscale – consciousness Measuring times: Baseline; Post-treatment; Follow-up Dealing with negative thoughts: Thought Control Questionnaire Measuring times: Baseline; Post-treatment; Follow-up Patient evaluation: Therapeutic Relationship: Working Alliance Inventory-S (adapted for Online self-help) Measuring times: intermediate measure, Post-treatment Evaluation/therapy satisfaction: Distress/Endorsment Validation Scale Measuring times: Post-treatment Other constructs: Theory of Planned Behavior: new development of TPB questionnaire in regards to Ajzen (sub-constructs: attitudes, perceived behavioural control, subjective norm, intention to use Online therapy) Measuring times: Baseline | — |
Countries
Algeria, Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libya, Mauritania, Morocco, Oman, Palestinian Territories, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, United Arab Emirates, Western Sahara, Yemen
Contacts
Zentrum Überleben gGmbH